These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Deficiency of syntrophin, dystroglycan, and merosin in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin. Tachi N; Ohya K; Chiba S; Matsuo M; Patria SY; Matsumura K Neurology; 1997 Aug; 49(2):579-83. PubMed ID: 9270600 [TBL] [Abstract][Full Text] [Related]
7. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. Kuang W; Xu H; Vachon PH; Liu L; Loechel F; Wewer UM; Engvall E J Clin Invest; 1998 Aug; 102(4):844-52. PubMed ID: 9710454 [TBL] [Abstract][Full Text] [Related]
8. β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice. Liu J; Milner DJ; Boppart MD; Ross RS; Kaufman SJ Hum Mol Genet; 2012 Apr; 21(7):1592-603. PubMed ID: 22180459 [TBL] [Abstract][Full Text] [Related]
9. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. Crosbie RH; Barresi R; Campbell KP FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321 [TBL] [Abstract][Full Text] [Related]
10. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals. Gawlik KI; Holmberg J; Durbeej M Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714 [TBL] [Abstract][Full Text] [Related]
11. The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability. Mendell JR; Sahenk Z; Prior TW J Child Neurol; 1995 Mar; 10(2):150-9. PubMed ID: 7782608 [TBL] [Abstract][Full Text] [Related]
12. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Matsumura K; Yamada H; Saito F; Sunada Y; Shimizu T Neuromuscul Disord; 1997 Jan; 7(1):7-12. PubMed ID: 9132144 [TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A. Doe JA; Wuebbles RD; Allred ET; Rooney JE; Elorza M; Burkin DJ J Cell Sci; 2011 Jul; 124(Pt 13):2287-97. PubMed ID: 21652631 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. Hodges BL; Hayashi YK; Nonaka I; Wang W; Arahata K; Kaufman SJ J Cell Sci; 1997 Nov; 110 ( Pt 22)():2873-81. PubMed ID: 9427295 [TBL] [Abstract][Full Text] [Related]
16. Merosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers. Shibuya S; Wakayama Y; Inoue M; Kojima H; Oniki H Med Electron Microsc; 2003 Dec; 36(4):213-20. PubMed ID: 16228654 [TBL] [Abstract][Full Text] [Related]
17. Confocal analysis of the dystrophin protein complex in muscular dystrophy. Draviam R; Billington L; Senchak A; Hoffman EP; Watkins SC Muscle Nerve; 2001 Feb; 24(2):262-72. PubMed ID: 11180210 [TBL] [Abstract][Full Text] [Related]
19. [Significance of merosin and sarcoglycan in manifestations of certain forms of muscular dystrophy]. Medić S; Rakocević-Stojanović V Srp Arh Celok Lek; 1998; 126(1-2):34-9. PubMed ID: 9525081 [TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of laminin beta 1 chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy. Li M; Dickson DW; Spiro AJ Arch Neurol; 1997 Dec; 54(12):1457-61. PubMed ID: 9400354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]